Potential Treatment for Infant Lung Disease
Posted on: Tuesday, 3 April 2007, 18:00 CDT
Massachusetts General Hospital and Genzyme Corp. have identified a possible treatment for a chronic lung disease in premature infants.
A study in American Journal of Physiology -- Lung Cellular and Molecular Physiology found a growth factor that plays a major role in lung disease, or bronchopulmonary dysplasia. Inhibiting the activity of this growth factor in an injured newborn lung may decrease the severity or incidence of the disease.
Senior author Dr. Jesse Roberts Jr. said the results are exciting, since bronchopulmonary dysplasia is the most common lung disease of premature infants.
The disease affects about 15 percent of premature infants and leads to chronic lung disease in 10,000 to 20,000 U.S. infants annually. Most of the infants -- 65 percent -- who are affected have a birth weight of less than 1 pound, 10 ounces.
Source: United Press International
Related Articles
- Your Oral Health Is Linked To Your Overall Health
- Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
- Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
- Inhaled Nitric Oxide Reduces Lung Disease in Premature Babies
- American Academy of Pediatrics and American Academy of Ophthalmology Issue New Guidelines for Eye Disease Screening in Premature Infants
- African-Americans Disproportionately Affected By Lung Disease; Lung Cancer Is Top 3 Killer
- Intestinal Disease Strikes Seven Premature Babies
- Stigma Follows Lung Cancer Nonsmokers, Such As Actress Dana Reeve, Also Get Deadly Disease Lung Cancer is the World's Top Cancer Killer
- Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Lung Biology in Health and Disease, Volume 183
- Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-Disordered Breathing in AJRCCM in 2004
 |
 |
User Comments (0)
RSS Feeds